Dr. Pathak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
265 Cohasset Rd
Chico, CA 95926Phone+1 530-332-4700Fax+1 530-893-6906
Education & Training
Tower HealthResidency, Internal Medicine, 2013 - 2016
Nepal Medical CollegeClass of 2011
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology
Certifications & Licensure
CA State Medical License 2020 - 2026
CT State Medical License 2017 - 2022
PA State Medical License 2013 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsTreatment Patterns and Clinical Outcomes in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer After Progression on Osimertinib.Nathaniel D Robinson, Maureen E Canavan, Peter L Zhan, Brooks V Udelsman, Ranjan Pathak
Clinical Lung Cancer. 2024-09-23 - Overcoming Barriers to Tobacco Cessation and Lung Cancer Screening among Racial and Ethnic Minority Groups and Underserved Patients in Academic Centers and Community N...Cary A Presant, Kimlin Ashing, Dan Raz, Sophia Yeung, Brenda Gascon
Journal of Clinical Medicine. 2023-02-06 - 2 citationsIncreasing clinician participation in tobacco cessation by an implementation science-based tobacco cessation champion program.Cary A Presant, Kimlin Ashing, Sophia Yeung, Jonjon Macalintal, Brian Tiep
Cancer Causes & Control. 2023-01-01
Journal Articles
- Adjuvant Chemotherapy in Patients with Early-Stage Non–Small Cell Lung Cancer—ReplyRanjan Pathak, MD, JAMA Oncology
- Association of Survival with Adjuvant Chemotherapy Among Patients with Early-Stage Non–Small Cell Lung Cancer with vs Without High-Risk Clinicopathologic FeaturesRanjan Pathak, MD, JAMA Oncology
Press Mentions
Apixaban Doesn't Appear to Boost Bleeding in Kidney DiseaseNovember 26th, 2014
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
